For retail and hospitality ISVs, January isn't for new features. It is for fixing what the holiday peak season broke. Here is ...

Google Cloud’s lead engineer for databases discusses the challenges of integrating databases and LLMs, the tools needed to ...

Baylor’s future under Dave Aranda might have just taken a thrilling turn. In a transfer portal season filled with quarterback ...

At the upcoming Visual Studio Live! Las Vegas developer conference, SQL expert Denny Cherry will share essential indexing ...

Bristol-Myers Squibb has won FDA approval for the first LAG-3 inhibitor drug ahead of its rivals in cancer immunotherapy, including Merck & Co. The US regulator cleared BMS' LAG-3 drug relatlimab as a ...